A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
复制标题
DOI：
10.1016/j.clim.2007.11.012
复制
发表时间：
2008-03
影响因子：
8.6
通讯作者：
J. Sutter;J. Kwan-Morley;J. Dunham;Yangzhu Du;M. Kamoun;D. Albert;R. Eisenberg;E. L. Luning Prak
中科院分区：
文献类型：
--
作者：
J. Sutter;J. Kwan-Morley;J. Dunham;Yangzhu Du;M. Kamoun;D. Albert;R. Eisenberg;E. L. Luning Prak
